What should you know about melanoma cancer vaccine?

Unlike a vaccine used to prevent an infection, a therapeutic cancer vaccine is designed to help the immune system recognise features of tumour cells. The exact approach depends on the vaccine, the melanoma stage, tumour findings, and the treatment plan. Some vaccine approaches are investigational, so availability and eligibility vary.

Melanoma care may also include removal of the visible tumour, assessment of nearby lymph nodes, or medicines that activate immune responses. Read about [Melanoma](/conditions/melanoma/) and [Immunotherapy](/treatments/systemic-therapy/immunotherapy/) to understand these broader options.

Ask the treating oncologist whether a vaccine is part of standard care, available through a clinical trial, or unsuitable for your melanoma. Bring pathology and scan reports, and tell the team about autoimmune illness, transplant history, allergies, and medicines that affect immunity. Do not delay recommended surgery or systemic treatment while looking for a vaccine option.

Contact your oncology team promptly for fever, chills, a spreading rash, breathing difficulty, persistent vomiting, severe diarrhoea, confusion, or a new neurological symptom after an immune-based treatment. A sudden seizure, fainting, severe weakness, or difficulty speaking needs emergency care.

Ask what the vaccine targets, what evidence supports its use for your situation, how it is given, which side effects need urgent attention, and how response will be monitored. Also ask whether [Sentinel Lymph Node Biopsy](/treatments/diagnostics-and-staging/sentinel-lymph-node-biopsy/) or [Follow-Up After Cancer Treatment](/treatments/survivorship-and-rehabilitation/post-treatment-surveillance/) applies to your plan.